NYSE:STE - STERIS Stock Price, Price Target & More

$95.93 +0.83 (+0.87 %)

(As of 04/26/2018 04:00 PM ET)

Previous Close$95.10

Today's Range$94.69 - $96.64

52-Week Range$72.85 - $97.47

Volume324,788 shs

Average Volume359,001 shs

Market Capitalization$8.08 billion

P/E Ratio25.43

Dividend Yield1.30%

Beta1.12

About STERIS (NYSE:STE)

STERIS plc develops, manufactures, and markets infection prevention, contamination control, microbial reduction, and surgical and gastrointestinal support products and services for healthcare, pharmaceutical, scientific, research, industrial, and governmental customers worldwide. The company's Healthcare Products segment offers steam, vaporized hydrogen peroxide, and ethylene oxide sterilizers, as well as liquid chemical sterilant processing systems; automated washer/disinfector systems; general and specialty surgical tables, surgical and examination lights, equipment management systems, operating room storage cabinets, warming cabinets, scrub sinks, and other accessories; and gastrointestinal devices and accessories. It also provides OR integration, OR and sterile processing department, workflow, patient tracking, and instrument management solutions; and cleaning chemistries and sterility assurance products. In addition, this segment offers preventive maintenance and repair, sterilization and surgical management consulting, and remote equipment monitoring services, as well as other support services. The company's Healthcare Specialty Services segment provides solutions, and outsourced and managed services for acute care hospitals and other healthcare settings, including instrument and endoscope repair and maintenance solutions; and custom process improvement consulting services. Its Life Sciences segment offers formulated cleaning chemistries, vaporized hydrogen peroxide generators, high-purity water equipment, steam sterilizers, and washers/disinfectors. The company's Applied Sterilization Technologies segment provides contract sterilization services using gamma, electron beam, and X-ray technologies, as well as ethylene oxide gas; and laboratory testing and validation services. It operates a network of 50 facilities. The company was founded in 1985 and is headquartered in Leicester, the United Kingdom.

Receive STE News and Ratings via Email

Sign-up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical appliances & supplies

Sub-IndustryHealth Care Equipment

SectorMedical

SymbolNYSE:STE

CUSIP85915210

Webwww.steris.com

Phone44-13-3238-7100

Debt

Debt-to-Equity Ratio0.46%

Current Ratio2.82%

Quick Ratio2.22%

Price-To-Earnings

Trailing P/E Ratio25.43

Forward P/E Ratio23.23

P/E GrowthN/A

Sales & Book Value

Annual Sales$2.61 billion

Price / Sales3.12

Cash Flow$6.7556 per share

Price / Cash14.20

Book Value$33.08 per share

Price / Book2.90

Profitability

EPS (Most Recent Fiscal Year)$3.76

Net Income$109.96 million

Net Margins9.42%

Return on Equity11.57%

Return on Assets6.80%

Miscellaneous

Employees12,000

Outstanding Shares84,850,000

STERIS (NYSE:STE) Frequently Asked Questions

What is STERIS's stock symbol?

STERIS trades on the New York Stock Exchange (NYSE) under the ticker symbol "STE."

How often does STERIS pay dividends? What is the dividend yield for STERIS?

STERIS declared a quarterly dividend on Wednesday, February 7th. Investors of record on Wednesday, February 28th will be paid a dividend of $0.31 per share on Wednesday, March 28th. This represents a $1.24 annualized dividend and a dividend yield of 1.29%. The ex-dividend date of this dividend is Tuesday, February 27th. This is a positive change from STERIS's previous quarterly dividend of $0.21. View STERIS's Dividend History.

How were STERIS's earnings last quarter?

STERIS (NYSE:STE) posted its quarterly earnings results on Wednesday, February, 7th. The medical equipment provider reported $1.12 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $1.07 by $0.05. The medical equipment provider had revenue of $661.90 million for the quarter, compared to the consensus estimate of $663.17 million. STERIS had a net margin of 9.42% and a return on equity of 11.57%. The business's revenue was up 2.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.98 EPS. View STERIS's Earnings History.

When is STERIS's next earnings date?

STERIS is scheduled to release their next quarterly earnings announcement on Tuesday, May, 8th 2018. View Earnings Estimates for STERIS.

What guidance has STERIS issued on next quarter's earnings?

STERIS updated its FY18 earnings guidance on Wednesday, February, 7th. The company provided earnings per share (EPS) guidance of $4.10-4.16 for the period, compared to the Thomson Reuters consensus EPS estimate of $4.05.

What price target have analysts set for STE?

5 Wall Street analysts have issued 1-year price targets for STERIS's stock. Their predictions range from $16.00 to $103.00. On average, they anticipate STERIS's stock price to reach $80.25 in the next year. View Analyst Ratings for STERIS.

Who are some of STERIS's key competitors?

Some companies that are related to STERIS include Edwards Lifesciences (EW), Zimmer Biomet (ZBH), Align Technology (ALGN), Smith & Nephew (SNN), Coloplast (CLPBY), William Demant (WILYY), Mine Safety Appliances (MSA), Inogen (INGN), Halyard Health (HYH), Wright Medical Group (WMGI), Consort Medical (CSRMY), Invacare (IVC), RTI Surgical (RTIX), Sientra (SIEN) and Lakeland Industries (LAKE).

Who are STERIS's key executives?

STERIS's management team includes the folowing people:

Mr. Walter M. Rosebrough Jr., Pres, CEO & Director (Age 64)
Mr. Michael J. Tokich, Sr. VP, CFO & Treasurer (Age 49)
Mr. John Adam Zangerle, VP, Gen. Counsel & Sec. (Age 51)
Mr. Daniel A. Carestio, Sr. VP of Applied Sterilization Technologies and Life Sciences (Age 45)
Dr. Adrian Vincent Coward, Sr. VP of Healthcare Specialty Services (Age 48)

Has STERIS been receiving favorable news coverage?

Media headlines about STE stock have been trending positive this week, according to Accern. The research firm identifies negative and positive news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. STERIS earned a news sentiment score of 0.28 on Accern's scale. They also assigned media headlines about the medical equipment provider an impact score of 46.64 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

How do I buy shares of STERIS?

Shares of STE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STERIS's stock price today?

One share of STE stock can currently be purchased for approximately $95.93.

How big of a company is STERIS?

STERIS has a market capitalization of $8.08 billion and generates $2.61 billion in revenue each year. The medical equipment provider earns $109.96 million in net income (profit) each year or $3.76 on an earnings per share basis. STERIS employs 12,000 workers across the globe.

How can I contact STERIS?

STERIS's mailing address is Rutherford House Stephensons Way Chaddesden, Derby X0, DE21 6LY. The medical equipment provider can be reached via phone at 44-13-3238-7100 or via email at [email protected]

MarketBeat Community Rating for STERIS (STE)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		157 (Vote Outperform)
Underperform Votes:		230 (Vote Underperform)
Total Votes:		387

MarketBeat's community ratings are surveys of what our community members think about STERIS and other stocks. Vote "Outperform" if you believe STE will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STE will underperform the S&P 500 over the long term. You may vote once every thirty days.

STERIS (NYSE:STE) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

5 Wall Street analysts have issued ratings and price targets for STERIS in the last 12 months. Their average twelve-month price target is $80.25, suggesting that the stock has a possible downside of 16.35%. The high price target for STE is $103.00 and the low price target for STE is $16.00. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus rating of "Buy."

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	Buy	Buy	Buy	Buy
Consensus Rating Score:	2.60	2.60	2.50	2.60
Ratings Breakdown:	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 2 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 2 Hold Rating(s) 3 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	$80.25	$80.25	$72.3333	$87.3333
Price Target Upside:	16.35% downside	4.68% downside	18.09% downside	3.68% downside

STERIS (NYSE:STE) Consensus Price Target History

Price Target History for STERIS (NYSE:STE)

STERIS (NYSE:STE) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
2/8/2018	KeyCorp	Reiterated Rating	Buy	$103.00	Medium
2/8/2018	Northcoast Research	Set Price Target	Buy	$102.00	Medium
1/3/2018	Raymond James	Reiterated Rating	Outperform -> Market Perform	$100.00	High
11/9/2017	TD Securities	Boost Price Target	Buy	C$14.00 -> C$16.00	N/A
6/5/2017	Wellington Shields	Downgrade	Gradually Accumulate -> Hold		Low
11/30/2016	Goldman Sachs	Initiated Coverage	Neutral	$71.00	N/A
11/4/2016	JMP Securities	Reiterated Rating	Buy		N/A

(Data available from 4/26/2016 forward)

STERIS (NYSE:STE) Earnings History and Estimates Chart

Earnings by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Earnings Estimates

2018 EPS Consensus Estimate: $4.05
2019 EPS Consensus Estimate: $4.78

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	2	$0.80	$0.82	$0.81
Q2 2018	2	$0.92	$0.94	$0.93
Q3 2018	2	$1.06	$1.11	$1.09
Q4 2018	2	$1.22	$1.22	$1.22
Q1 2019	1	$0.99	$0.99	$0.99
Q2 2019	1	$1.12	$1.12	$1.12
Q3 2019	1	$1.28	$1.28	$1.28
Q4 2019	1	$1.39	$1.39	$1.39

STERIS (NYSE STE) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
5/8/2018		$1.20					N/A
2/7/2018	Q3 2018	$1.07	$1.12	$663.17 million	$661.90 million	View	N/A
11/1/2017	Q2 2018	$0.95	$0.94	$629.02 million	$634.20 million	View	N/A
8/8/2017	Q1 2018	$0.80	$0.85	$597.66 million	$608.00 million	View	Listen
5/9/2017	Q4	$1.07	$1.11	$673.47 million	$681.20 million	View	Listen
2/7/2017	Q317	$1.04	$0.98	$680.13 million	$646.80 million	View	Listen
11/2/2016	Q217	$0.90	$0.89	$670.24 million	$646.40 million	View	N/A
8/9/2016	Q117	$0.77	$0.79	$639.04 million	$638.40 million	View	Listen
5/18/2016	Q416	$1.04	$0.90	$701.92 million	$690.30 million	View	Listen
2/9/2016	Q316	$0.94	$0.98	$617.35 million	$618.70 million	View	N/A
10/30/2015	Q216	$0.76	$0.83	$488.66 million	$489.90 million	View	Listen
8/4/2015	Q415	$0.61	$0.62	$439.23 million	$439.90 million	View	Listen
5/7/2015	Q4	$0.89	$0.98	$520.07 million	$501.60 million	View	Listen
2/4/2015	Q315	$0.73	$0.79	$475.22 million	$473.20 million	View	Listen
11/4/2014	Q215	$0.62	$0.68	$452.50 million	$462.70 million	View	Listen
8/5/2014	Q115	$0.54	$0.54	$418.26 million	$412.60 million	View	Listen
5/8/2014	Q4	$0.86	$0.91	$455.92 million	$465.30 million	View	Listen
2/5/2014	Q314	$0.69	$0.59	$406.40 million	$405.60 million	View	Listen
10/30/2013	Q214	$0.54	$0.55	$376.82 million	$383.80 million	View	Listen
8/7/2013	Q1 2014	$0.56	$0.44	$372.69 million	$367.70 million	View	Listen
5/7/2013	Q4 2013	$0.65	$0.70	$405.79 million	$426.20 million	View	Listen
2/6/2013	Q3 2013	$0.56	$0.58	$368.84 million	$380.40 million	View	Listen
10/31/2012	Q213	$0.52	$0.53	$350.23 million	$356.30 million	View	N/A
8/2/2012		$0.44	$0.53			View	N/A
5/8/2012		$0.60	$0.59			View	N/A
2/7/2012		$0.60	$0.58			View	N/A
11/2/2011		$0.57	$0.50			View	N/A
8/2/2011		$0.50	$0.46			View	N/A
5/9/2011		$0.62	$0.61			View	N/A
2/8/2011		$0.58	$0.57			View	N/A
11/3/2010	Q2 2011	$0.54	$0.55			View	N/A
8/3/2010	Q1 2011	$0.45	$0.46			View	N/A
5/6/2010	Q4 2010	$0.53	$0.55			View	N/A
2/2/2010	Q3 2010	$0.47	$0.69			View	N/A
11/3/2009	Q2 2010	$0.43	$0.54			View	N/A
7/30/2009	Q1 2010	$0.41	$0.43			View	N/A
5/7/2009	Q4 2009	$0.38	$0.49			View	N/A
1/27/2009	Q3 2009	$0.37	$0.53			View	N/A
10/30/2008	Q2 2009	$0.34	$0.48			View	N/A
7/30/2008	Q1 2009	$0.27	$0.43			View	N/A
5/7/2008	Q4 2008	$0.50	$0.59			View	N/A
1/30/2008	Q3 2008	$0.38	$0.35			View	N/A

(Earnings results data provided by Zacks Investment Research)

STERIS (NYSE:STE) Dividend Information

STERIS pays an annual dividend of $1.24 per share, with a dividend yield of 1.29%. STE's most recent quarterly dividend payment was Wednesday, March 28. The company has grown its dividend for the last 8 consecutive years and is increasing its dividend by an average of 10.30% each year. STERIS pays out 32.98% of its earnings out as a dividend.

Most Recent Dividend:	3/28/2018
Annual Dividend:	$1.24
Dividend Yield:	1.29%
Dividend Growth:	10.30% (3 Year Average)
Payout Ratio:	32.98% (Trailing 12 Months of Earnings) 30.02% (Based on This Year's Estimates) 26.33% (Based on Next Year's Estimates)
Track Record:	8 Years of Consecutive Dividend Growth
Frequency:	Quarterly Dividend

Dividend Payments by Quarter for STERIS (NYSE:STE)

STERIS (NYSE:STE) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
2/7/2018	quarterly	$0.31	1.35%	2/27/2018	2/28/2018	3/28/2018
11/1/2017	Quarterly	$0.31	1.42%	11/21/2017	11/22/2017	12/20/2017
8/8/2017	Quarterly	$0.31	1.46%	8/25/2017	8/29/2017	9/28/2017
5/9/2017	Quarterly	$0.28		6/5/2017	6/7/2017	6/29/2017
2/7/2017	Quarterly	$0.28	1.67%	2/24/2017	2/28/2017	3/28/2017
11/2/2016	Quarterly	$0.28	1.69%	11/21/2016	11/23/2016	12/21/2016
8/9/2016	Quarterly	$0.28	1.6%	8/26/2016	8/30/2016	9/27/2016
5/18/2016	quarterly	$0.25	1.43%	6/6/2016	6/8/2016	6/29/2016
2/9/2016	Quarterly	$0.25		2/26/2016	3/1/2016	3/29/2016
10/19/2015	quarterly	$0.25	1.45%	10/28/2015	10/30/2015	12/18/2015
8/5/2015	quarterly	$0.25	1.45%	8/21/2015	8/25/2015	9/22/2015
5/7/2015	quarterly	$0.23	1.35%	6/1/2015	6/3/2015	6/25/2015
2/5/2015	quarterly	$0.23	1.36%	2/23/2015	2/25/2015	3/25/2015
11/5/2014	quarterly	$0.23	1.47%	11/24/2014	11/26/2014	12/23/2014
8/6/2014	quarterly	$0.23	1.79%	8/22/2014	8/26/2014	9/23/2014
5/14/2014	quarterly	$0.21	1.58%	6/3/2014	6/5/2014	6/26/2014
2/6/2014	quarterly	$0.21	1.91%	2/24/2014	2/26/2014	3/26/2014
10/30/2013		$0.21		11/18/2013	11/20/2013	12/18/2013
8/7/2013	quarterly	$0.21	1.91%	8/26/2013	8/28/2013	9/25/2013
5/8/2013	quarterly	$0.19	1.69%	5/31/2013	6/4/2013	6/25/2013
2/7/2013	quarterly	$0.19	1.93%	2/25/2013	2/27/2013	3/27/2013

(Data available from 1/1/2013 forward)

STERIS (NYSE STE) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 2.55%
Institutional Ownership Percentage: 89.36%

Insider Trading History for STERIS (NYSE:STE)

Institutional Ownership by Quarter for STERIS (NYSE:STE)

STERIS (NYSE STE) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/23/2018	Sudhir K. Pahwa	VP	Sell	19	$97.00	$1,843.00
4/18/2018	Sudhir K. Pahwa	VP	Sell	1,981	$97.11	$192,374.91
3/12/2018	Walter M Rosebrough Jr	CEO	Sell	10,000	$95.50	$955,000.00
3/5/2018	Richard Martin Steeves	Director	Sell	58,953	$91.00	$5,364,723.00	9,362
2/28/2018	Jacqueline B Kosecoff	Director	Sell	2,744	$91.94	$252,283.36
2/26/2018	Cynthia L Feldmann	Director	Sell	3,218	$91.35	$293,964.30	11,214
2/13/2018	Karen L Burton	VP	Sell	1,500	$85.59	$128,385.00
1/29/2018	Sudhir K. Pahwa	VP	Sell	2,000	$92.09	$184,180.00
11/14/2017	John Adam Zangerle	VP	Sell	3,650	$88.00	$321,200.00
10/23/2017	Michael J Tokich	Insider	Sell	11,000	$92.00	$1,012,000.00	58,588
10/4/2017	Michael J Tokich	Insider	Sell	12,000	$89.75	$1,077,000.00
10/4/2017	Walter M Rosebrough Jr	CEO	Sell	10,000	$90.50	$905,000.00
9/8/2017	Richard Martin Steeves	Director	Sell	156,072	$87.13	$13,598,553.36	9,362
8/16/2017	Walter M Rosebrough Jr	CEO	Sell	10,000	$85.69	$856,900.00	83,270
8/15/2017	Karen L Burton	VP	Sell	3,270	$85.70	$280,239.00	11,807
8/9/2017	Mohsen Sohi	Director	Sell	2,744	$85.98	$235,929.12	21,816
7/3/2017	Michael B Wood	Director	Sell	4,000	$81.50	$326,000.00	26,131
6/16/2017	Kathleen Bardwell	Insider	Sell	3,795	$82.00	$311,190.00	20,605
6/13/2017	Daniel A. Carestio	Insider	Sell	4,745	$80.08	$379,979.60
6/2/2017	Walter M. Rosebrough, Jr.	CEO	Sell	10,000	$80.05	$800,500.00
6/1/2017	Kathleen Bardwell	Insider	Sell	4,000	$79.00	$316,000.00	20,975
6/1/2017	Sudhir K Pahwa	VP	Sell	3,000	$79.07	$237,210.00	22,047
5/25/2017	Sudhir K. Pahwa	VP	Sell	800	$77.28	$61,824.00
5/9/2017	Michael J Tokich	CFO	Sell	13,600	$76.00	$1,033,600.00	58,106
5/9/2017	Sudhir K. Pahwa	VP	Sell	200	$77.00	$15,400.00
5/3/2017	Daniel A Carestio	Insider	Sell	7,590	$75.17	$570,540.30	25,390
5/3/2017	John Adam Zangerle	VP	Sell	3,150	$75.00	$236,250.00	26,639
5/3/2017	Michael B Wood	Director	Sell	4,000	$75.00	$300,000.00	30,131
5/3/2017	Michael J Tokich	CFO	Sell	2,000	$75.00	$150,000.00	46,506
2/13/2017	Mohsen Sohi	Director	Sell	3,387	$67.66	$229,164.42	24,421
1/17/2017	Kathleen Bardwell	Insider	Sell	1,962	$68.78	$134,946.36	16,538
12/13/2016	John Adam Zangerle	VP	Sell	3,100	$69.00	$213,900.00	26,589
12/8/2016	Daniel A Carestio	Insider	Sell	2,225	$67.54	$150,276.50	20,025
11/15/2016	John Adam Zangerle	VP	Sell	2,200	$67.00	$147,400.00	26,166
11/4/2016	Cynthia L Feldmann	Director	Sell	4,744	$64.98	$308,265.12	14,581
9/7/2016	Richard Martin Steeves	Director	Sell	204,778	$71.19	$14,578,145.82	165,434
8/31/2016	Adrian Vincent Coward	Insider	Sell	15,000	$69.00	$1,035,000.00
8/26/2016	Sudhir K. Pahwa	VP	Sell	1,028	$70.13	$72,093.64
8/17/2016	Walter M. Rosebrough, Jr.	CEO	Sell	15,000	$71.08	$1,066,200.00
8/12/2016	Daniel A. Carestio	Insider	Sell	2,681	$71.04	$190,458.24
2/17/2016	Walter M. Rosebrough, Jr.	CEO	Sell	10,000	$64.27	$642,700.00
11/18/2015	Walter M Rosebrough Jr	CEO	Sell	11,960	$75.58	$903,936.80	111,376
11/9/2015	Kathleen Bardwell	insider	Sell	2,496	$73.85	$184,329.60	13,235
11/9/2015	Kevin M. Mcmullen	Director	Sell	8,000	$73.73	$589,840.00	26,338
11/3/2015	Mohsen Sohi	Director	Sell	3,000	$76.36	$229,080.00	20,250
10/30/2015	Daniel A. Carestio	insider	Sell	6,270	$74.00	$463,980.00	16,800
10/28/2015	Sudhir K Pahwa	VP	Sell	1,000	$70.09	$70,090.00	21,289
9/30/2015	Walter M Rosebrough Jr	CEO	Sell	5,000	$64.92	$324,600.00	116,376
9/29/2015	Walter M Rosebrough Jr	CEO	Sell	10,000	$64.43	$644,300.00	121,376
6/15/2015	David Allen Johnson	VP	Sell	1,826	$63.08	$115,184.08
6/10/2015	Walter M Rosebrough Jr	CEO	Sell	20,000	$63.80	$1,276,000.00
6/9/2015	Walter M Rosebrough Jr	CEO	Sell	5,000	$63.56	$317,800.00
8/11/2014	Michael B Wood	Director	Sell	5,300	$51.79	$274,487.00
6/2/2014	John Adam Zangerle	VP	Sell	2,000	$53.45	$106,900.00
5/12/2014	John Wareham	Director	Sell	15,000	$55.09	$826,350.00	23,256
4/2/2014	Michael Tokich	CFO	Sell	4,525	$51.68	$233,852.00	30,320
1/8/2014	Michael Tokich	CFO	Sell	4,200	$48.72	$204,624.00	30,320
11/26/2013	Cynthia Feldmann	Director	Sell	6,254	$45.97	$287,496.38	10,000
8/8/2013	Timothy Chapman	SVP	Sell	10,000	$43.84	$438,400.00	21,581
6/12/2013	Kevin M Mcmullen	Director	Sell	10,000	$44.09	$440,900.00
5/30/2013	Walter M Rosebrough Jr	CEO	Sell	2,000	$45.72	$91,440.00
5/22/2013	Mohsen Sohi	Director	Sell	10,000	$45.21	$452,100.00
5/21/2013	William L Aamoth	Treasurer	Sell	6,150	$45.96	$282,654.00
5/13/2013	David Allen Johnson	VP	Sell	2,680	$44.99	$120,573.20
10/5/2012	Michael J Tokich	CFO	Sell	4,100	$37.00	$151,700.00
8/9/2012	Cynthia L Feldmann	Director	Sell	23,122	$34.05	$787,304.10

(Data available from 1/1/2013 forward)

STERIS (NYSE STE) News Headlines

Source:

Date	Headline
	STERIS to Announce Fiscal 2018 Fourth Quarter and Full Year Financial Results on May 9, 2018 finance.yahoo.com - April 25 at 4:49 PM
	Varex Imaging Names Rosebrough To Board Of Directors finance.yahoo.com - April 23 at 8:56 AM
	STERIS (STE) VP Sudhir K. Pahwa Sells 1,981 Shares www.americanbankingnews.com - April 19 at 7:35 PM
	STERIS (STE) Expected to Post Quarterly Sales of $709.63 Million www.americanbankingnews.com - April 16 at 2:17 AM
	BidaskClub Downgrades STERIS (STE) to Buy www.americanbankingnews.com - April 14 at 9:13 PM
	$1.22 EPS Expected for STERIS (STE) This Quarter www.americanbankingnews.com - April 14 at 7:18 PM
	Medical Instrument Stocks Head-to-Head: Abiomed vs. STERIS finance.yahoo.com - April 13 at 9:29 AM
	STERIS (STE) Downgraded to "Hold" at Zacks Investment Research www.americanbankingnews.com - April 12 at 11:12 AM
	Steris PLC (STE) Receives Consensus Recommendation of "Buy" from Brokerages www.americanbankingnews.com - April 7 at 1:29 AM
	KeyCorp Reaffirms "Buy" Rating for Steris (STE) www.americanbankingnews.com - April 6 at 9:16 PM
	Steris (STE) Rating Lowered to Hold at Zacks Investment Research www.americanbankingnews.com - April 6 at 12:35 PM
	Steris (STE) Rating Increased to Buy at Zacks Investment Research www.americanbankingnews.com - April 5 at 1:55 PM
	Steris (STE) Rating Reiterated by KeyCorp www.americanbankingnews.com - April 2 at 8:20 AM
	Steris PLC (STE) Expected to Announce Quarterly Sales of $709.63 Million www.americanbankingnews.com - March 30 at 1:50 AM
	$1.22 EPS Expected for Steris PLC (STE) This Quarter www.americanbankingnews.com - March 28 at 11:12 PM
	Steris (STE) Downgraded by Zacks Investment Research to "Hold" www.americanbankingnews.com - March 28 at 2:41 PM
	Steris (STE) Raised to "Buy" at Zacks Investment Research www.americanbankingnews.com - March 27 at 2:54 PM
	Steris Target of Unusually Large Options Trading (STE) www.americanbankingnews.com - March 27 at 6:54 AM
	Global Low Temperature Sterilization Market Analysis & Outlook 2018-2022 Featuring Johnson & Johnson, 3M, Getinge and Steris - ResearchAndMarkets.com www.businesswire.com - March 23 at 9:10 AM
	Favorable Market Trend & Core Business Expansion Aid STERIS www.zacks.com - March 21 at 10:14 AM
	Zacks Investment Research Downgrades Steris (STE) to Hold www.americanbankingnews.com - March 20 at 2:58 PM
	The global patient positioning systems market is anticipated to reach USD 1.4 billion by 2025 www.prnewswire.com - March 20 at 9:24 AM
	Zacks Investment Research Upgrades Steris (STE) to Buy www.americanbankingnews.com - March 19 at 1:45 PM
	Steris Corp. Looks Bullish on Our Charts - Further Gains Ahead finance.yahoo.com - March 16 at 5:40 PM
	Steris PLC (STE) CEO Walter M. Rosebrough, Jr. Sells 10,000 Shares www.americanbankingnews.com - March 13 at 7:32 PM
	$709.63 Million in Sales Expected for Steris PLC (STE) This Quarter www.americanbankingnews.com - March 13 at 8:55 AM
	Steris PLC (STE) Given Consensus Rating of "Buy" by Analysts www.americanbankingnews.com - March 13 at 1:46 AM
	Steris PLC (STE) Expected to Post Earnings of $1.22 Per Share www.americanbankingnews.com - March 11 at 4:51 PM
	Why Is STERIS (STE) Up 7.7% Since Its Last Earnings Report? finance.yahoo.com - March 9 at 5:45 PM
	Richard Martin Steeves Sells 58,953 Shares of Steris PLC (STE) Stock www.americanbankingnews.com - March 7 at 6:16 PM
	Tamarack Advisers LP Invests $2.19 Million in Steris PLC (STE) www.americanbankingnews.com - March 6 at 10:30 AM
	Steris PLC (STE) Shares Sold by Brown Advisory Inc. www.americanbankingnews.com - March 4 at 5:03 AM
	Steris PLC (STE) Holdings Cut by Schroder Investment Management Group www.americanbankingnews.com - March 3 at 8:53 AM
	Channing Capital Management LLC Has $14.28 Million Holdings in Steris PLC (STE) www.americanbankingnews.com - March 3 at 5:50 AM
	Steris PLC (STE) Holdings Lowered by Credit Agricole S A www.americanbankingnews.com - March 3 at 5:30 AM
	Bank of New York Mellon Corp Acquires 958 Shares of Steris PLC (STE) www.americanbankingnews.com - March 3 at 4:42 AM
	Snyder Capital Management L P Increases Holdings in Steris PLC (STE) www.americanbankingnews.com - March 2 at 1:57 PM
	Carillon Tower Advisers Inc. Invests $4.35 Million in Steris PLC (STE) www.americanbankingnews.com - March 2 at 5:34 AM
	Insider Selling: Steris PLC (STE) Director Sells 2,744 Shares of Stock www.americanbankingnews.com - March 1 at 10:08 PM
	Steris PLC (STE) Position Increased by The Manufacturers Life Insurance Company www.americanbankingnews.com - March 1 at 6:04 PM
	Steris PLC (STE) Stake Lessened by Sei Investments Co. www.americanbankingnews.com - February 28 at 5:22 PM
	Steris PLC (STE) Director Sells $293,964.30 in Stock www.americanbankingnews.com - February 27 at 6:52 PM
	Steris PLC (STE) Shares Bought by First Republic Investment Management Inc. www.americanbankingnews.com - February 27 at 12:48 PM
	Rhumbline Advisers Buys 14,410 Shares of Steris PLC (STE) www.americanbankingnews.com - February 27 at 11:26 AM
	STERIS Focuses on Expanding Core Business, Competition Rife www.zacks.com - February 27 at 9:13 AM
	Liberty Mutual Group Asset Management Inc. Lowers Stake in Steris PLC (STE) www.americanbankingnews.com - February 27 at 7:32 AM
	Steris PLC (STE) Shares Sold by Champlain Investment Partners LLC www.americanbankingnews.com - February 27 at 5:38 AM
	Steris PLC (STE) Shares Bought by BlackRock Inc. www.americanbankingnews.com - February 27 at 4:54 AM
	Suntrust Banks Inc. Buys 14,447 Shares of Steris PLC (STE) www.americanbankingnews.com - February 26 at 9:38 AM
	Arizona State Retirement System Purchases 13,057 Shares of Steris PLC (STE) www.americanbankingnews.com - February 25 at 4:14 AM

STERIS (NYSE:STE) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

STERIS (NYSE:STE) Income Statement, Balance Sheet and Cash Flow Statement

STERIS (NYSE STE) Stock Chart for Thursday, April, 26, 2018

Loading chart…

This page was last updated on 4/26/2018 by MarketBeat.com Staff